ID

18986

Descripción

Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00134654

Link

https://clinicaltrials.gov/show/NCT00134654

Palabras clave

Versiones (1)
  1. 28/11/16 28/11/16 -
Subido en

28 de noviembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00134654

Inglés

Eligibility Prostate Cancer NCT00134654

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
documented histologic evidence of prostate cancer.
Descripción

Prostate carcinoma Evidence of

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0332120
progressive androgen-independent prostate cancer as defined by the prostate-specific antigen (psa) working group after conventional androgen deprivation and antiandrogen withdrawal.
Descripción

androgen independent prostate cancer Progressive | androgen suppression conventional | Androgen Antagonists Withdrawal

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1654637
UMLS CUI [1,2]
C0205329
UMLS CUI [2,1]
C1515985
UMLS CUI [2,2]
C0439858
UMLS CUI [3,1]
C0002842
UMLS CUI [3,2]
C2349954
psa > 2ng/ml and serum testosterone of < 50ng/ml
Descripción

Prostate specific antigen measurement | Serum testosterone measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201544
UMLS CUI [2]
C0428413
no history of thromboembolic disease within the prior year
Descripción

Thromboembolism

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0040038
ecog performance status of 0-2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
creatinine < 2 x upper limit of normal
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
bilirubin < 2 x upper limit of normal
Descripción

Serum total bilirubin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
ast < 2 x upper limit of normal
Descripción

Aspartate aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
unstable angina or change in anginal symptoms within the past 6 months.
Descripción

Angina, Unstable | angina symptom Change

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0002965
UMLS CUI [2,1]
C0858277
UMLS CUI [2,2]
C0392747
prior therapy with estrogens or pc-specs.
Descripción

Estrogens | PC-SPES

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0014939
UMLS CUI [2]
C0756934
concurrent megestrol acetate or steroid hormones
Descripción

Megestrol Acetate | Steroid hormone

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0065879
UMLS CUI [2]
C0301818
major surgery or radiation therapy within 4 weeks
Descripción

major surgery | Therapeutic radiology procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2]
C1522449
strontium-89 or samarium-153 therapy within 8 weeks
Descripción

Strontium-89 | SAMARIUM Sm153

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0281385
UMLS CUI [2]
C0677942
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT00134654

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma Evidence of
Item
documented histologic evidence of prostate cancer.
boolean
C0600139 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
androgen independent prostate cancer Progressive | androgen suppression conventional | Androgen Antagonists Withdrawal
Item
progressive androgen-independent prostate cancer as defined by the prostate-specific antigen (psa) working group after conventional androgen deprivation and antiandrogen withdrawal.
boolean
C1654637 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
C1515985 (UMLS CUI [2,1])
C0439858 (UMLS CUI [2,2])
C0002842 (UMLS CUI [3,1])
C2349954 (UMLS CUI [3,2])
Prostate specific antigen measurement | Serum testosterone measurement
Item
psa > 2ng/ml and serum testosterone of < 50ng/ml
boolean
C0201544 (UMLS CUI [1])
C0428413 (UMLS CUI [2])
Thromboembolism
Item
no history of thromboembolic disease within the prior year
boolean
C0040038 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0-2
boolean
C1520224 (UMLS CUI [1])
Creatinine measurement, serum
Item
creatinine < 2 x upper limit of normal
boolean
C0201976 (UMLS CUI [1])
Serum total bilirubin measurement
Item
bilirubin < 2 x upper limit of normal
boolean
C1278039 (UMLS CUI [1])
Aspartate aminotransferase measurement
Item
ast < 2 x upper limit of normal
boolean
C0201899 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Angina, Unstable | angina symptom Change
Item
unstable angina or change in anginal symptoms within the past 6 months.
boolean
C0002965 (UMLS CUI [1])
C0858277 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
Estrogens | PC-SPES
Item
prior therapy with estrogens or pc-specs.
boolean
C0014939 (UMLS CUI [1])
C0756934 (UMLS CUI [2])
Megestrol Acetate | Steroid hormone
Item
concurrent megestrol acetate or steroid hormones
boolean
C0065879 (UMLS CUI [1])
C0301818 (UMLS CUI [2])
major surgery | Therapeutic radiology procedure
Item
major surgery or radiation therapy within 4 weeks
boolean
C0679637 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
Strontium-89 | SAMARIUM Sm153
Item
strontium-89 or samarium-153 therapy within 8 weeks
boolean
C0281385 (UMLS CUI [1])
C0677942 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial